Recent News

• 02.28.2025 - Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
• 01.30.2025 - Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
• 01.29.2025 - Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
• 01.29.2025 - Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

Recent Filings

• 02.28.2025 - 8-K Current report
• 02.28.2025 - EX-99.1 EX-99.1
• 02.28.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities